Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 2, 2007, Pages 235-241

  Sowunmi, Akintunde ^a,b   Gbotosho, Grace O ^a,b   Happi, Christian T ^a,b   Adedeji, Ahmed A ^a,b   Fehintola, Fatai A ^a,b   Folarin, Onikepe A ^a,b   Tambo, Ernest ^a,b   Fateye, Babasola A ^a,b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; METAKELFIN; ANTIMALARIAL AGENT; ARTEMETHER LUMEFANTRINE COMBINATION; ARTEMETHER-LUMEFANTRINE COMBINATION; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PYRIMETHAMINE; SULFALENE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANEMIA; ARTICLE; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DARK URINE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; GAMETOCYTE; HEADACHE; HUMAN; INFANT; INSOMNIA; JAUNDICE; MAJOR CLINICAL STUDY; MALARIA; MALE; NIGERIA; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; URINE COLOR; VOMITING; WEAKNESS; ANIMAL; BLOOD; DRUG COMBINATION; GROWTH, DEVELOPMENT AND AGING; MALARIA FALCIPARUM; PARASITOLOGY; PRESCHOOL CHILD;

PLASMODIUM FALCIPARUM;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; NIGERIA; PARASITEMIA; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFALENE;

EID: 34848857027     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.235     Document Type: Article

References (47)

1. World Health Organization, 2001. Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation. Geneva: World Health Organization. WHO/CDS/RBM/2001.35.
2. Trape J-F, Pison G, Preziosi M-P, Enel C, Du Lou AD, Delaunay V, Samb B, Lagarde E, Molez J-F, Simondon F, 1998. Impact of chloroquine resistance on malaria mortality. Life Sci 321: 689-697.
3. Trape JF, 2001. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 64 (Suppl 1-2): 12-17.
4. White N, 1999. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 354: 739-749.
5. Hien TT, White NJ, 1993. Qinghaosu. Lancet 341: 603-608.
6. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajasiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654-1658.
7. Price R, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chongsuphajaisiddhi T, White NJ, 1998. Artesunate versus artemether for the treatment of recrudescent multi-drug resistant falciparum malaria. Am J Trop Med Hyg 59: 883-888.
8. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui P-B, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WRJ, 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial. Lancet 359: 1365-1372.
9. Bloland PB, Ettling M, Meek S, 2000. Combination therapy for malaria in Africa: hype or hope? Bull World Health Organ 78: 1378-1388.
10. Bloland PB, 2003. A contrarian view of malaria therapy policy in Africa. Am J Trop Med Hyg 68: 125-126.
11. Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamya MR, 2003. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68: 127-132.
12. Sowunmi A, 2002. A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Ann Trop Med Parasitol 96: 227-238.
13. Irare SA, Lemnge MM, Mhina JI, 1991. Falciparum malaria cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania. Trop Geogr Med 43: 352-356.
14. Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Tambo E, Fateye BA, Happi TC, Oduola AMJ, 2005. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Trop Med Int Health 10: 1161-1170.
15. Salako LA, Ajayi FO, Sowunmi A, Walker O, 1990. Malaria in Nigeria: a revisit. Ann Trop Med Parasitol 84: 435-445.
16. World Health Organization, 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1): 1-90.
17. Happi TC, Thomas SM, Gbotosho GO, Falade CO, Akinboye DO, Gerena L, Hudson T, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AMJ, 2003. Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann Trop Med Parasitol 97: 439-451.
18. Happi CT, Gbotosho GO, Sowunmi A, Falade CO, Akinboye DO, Gerena L, Kyle DE, Milhous W, Wirth DF, Oduola AM, 2004. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. Am J Trop Med Hyg 70: 20-26.
19. Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AMJ, 2005. Polymorphism in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop 95: 183-193.
20. Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AMJ, 2006. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg 75: 155-161.
21. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. World Health Organ Tech Rep Ser 529: 1-121.
22. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Geneva: World Health Organization. WHO/HTM/RBM/2003.50.
23. Anonymous, 1994. Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers. Atlanta, GA: Centers for Disease Control and Prevention.
24. Anonymous, 1999. SPSS for Windows Release 10.01 (Standard Version). Chicago. IL: SPSS Inc.
25. Schellenberg D, Kahigwa E, Drakeley C, Malende A, Wigayi J, Msokame C, Aponte JJ, Tanner M, Mshinda H, Menendez C, Alonso PL, 2002. The safety and efficacy of sulfadoxine-pyrimerihamine, amodiaquine and their combination in the treatment of uncomplicated falciparum malaria. Am J Trop Med Hyg 67: 17-23.
26. Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull World Health Organ 80: 538-545.
27. Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ, 2003. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. J Infect Dis 188: 1231-1238.
28. Staedke SG, Mpimbaza A, Kamya MR, Nzarubaba BK, Dorsey G, Rosenthal PJ, 2004. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomized clinical trial. Lancet 364: 1950-1957.
29. Talisuna AO, Nalunkuma-Kazibwe A, Bakyaita N, Langt P, Mutabingwa TK, Watkins WM, van Marck E, D'Alessandro U, Egwang TG, 2004. Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Trop Med Inter Hlth 9: 222-229.
30. Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Lankoade M, Ouedraogo JB, Rosenthal PJ, 2005. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized control trial from Burkina Faso. Am J Trop Med Hyg 73: 826-832.
31. Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya ME, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, 2005. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials in Uganda. PloS Med 2: e190.
32. Sowunmi A, Walker O, Salako LA, 1989. Pruritus and antimalarial drugs in Africans. Lancet 2: 213.
33. Hatton C, Peto T, Bunch C, Pasvol G, Russell S, Singer C, Edwards G, Winstanley P, 1986. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet i: 411-413.
34. Sowunmi A, Salako LA, 1992. Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria. Ann Trop Med Parasitol 86: 1-8.
35. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ, 1999. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 60: 1019-1023.
36. von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G, 2001. Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 65: 523-527.
37. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Happi TC, 2004. Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology 129: 255-262.
38. Puta C, Manyando C, 1997. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Trop Med Int Health 2: 227-229.
39. Sowunmi A, Fateye BA, 2003. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop Med Int Health 8: 783-792.
40. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Bamgboye AE, Babalola CP, Happi TC, Gbotosho GO, 2005. Effects of antifolates-co-trimoxazole and pyrimethamine-sulfadoxine on gametocytes in children with acute, symptomatic, uncomplicated Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 100: 451-455.
41. Sowunmi A, Adedeji AA, Gbotosho GO, Fateye BA, Happi TC, 2006. Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated Plasmodium falciparum malaria in children. Mem Inst Oswaldo Cruz 101: 887-893.
42. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G, 2001. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6: 92-98.
43. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P, 2001. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis 183: 1254-1259.
44. Drakeley CJ, Seeka I, Correa S, Greenwood BM, Targett GAT, 2000. Host factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae S.S. mosquitoes. Trop Med Int Health 4: 131-138.
45. Drakeley CJ, Jawara M, Targett GAT, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ, 2003. Addition of artesunate to chloroquine for the treatment of P. falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 9: 53-61.
46. Bousema JT, Schneider P, Gougna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, 2006. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 193: 1151-1159.
47. Oduola AMJ, Sowunmi A, Milhous WK, Kyle DE, Martin RK, Walker O, Salako LA, 1992. Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg 86: 123-126.